In a world first, the Medicines and Healthcare Products Regulatory Agency (MHRA) has approved trofolastat to detect cancerous lesions in men with prostate cancer.
Could cannabis for cancer become a reality in patient wards? Researchers find the plant can improve sleep, pain, and brain clarity, easing 'chemo brain'.
AI offers an opportunity to reimagine our approach to cancer diagnostics, leveraging data to build a more robust and efficient system for cancer referrals.
HPV is the most common STI in the world, affecting 80% of the population. Here Dr Deborah Lee, from Dr Fox Online Pharmacy, addresses the most common issues about HPV in an attempt to aid in the understanding of the condition
Researchers have revealed a new and non-invasive way to detect brain tumours through a device that identifies a key membrane protein in a patient's urine.
Researchers discover drug combination that could offer a better prognosis for children diagnosed with MYC amplified Medulloblastoma, an often deadly form of brain cancer.
Prof Richard M Hall, School of Mechanical Engineering, University of Leeds, explores how oncological engineering is paving the way for new and innovative cancer treatments.
British Skin Foundation walk us through the two main types of skin cancer, melanoma & non-melanoma, and the importance of funding research in the field.
The Canadian Institutes of Health Research (CIHR), a Canadian healthcare research investment agency, collaborates with partners to innovate health improvements.
